VIPERGEN R & D III K/S: Financial statements 2016
CVR: 30355644
Source: annual report 2016, Danish Business Authority
01/01/2016 – 31/12/2016
VIPERGEN R & D III K/S (CVR 30355644) has filed annual accounts for 2016. In 2016, the company reported a net result of DKK -52,000 compared with DKK -932,000 the year before. Equity in the 2016 report amounted to DKK -52,000.
- Profit/Loss
- DKK -52,000
- Equity
- DKK -52,000
- Total Assets
- DKK 2,258,000
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2016 | - | - | -52K | -52K | - |
| 2015 | 0 | - | -932K | 0 | - |
| 2014 | 805K | - | -12.3M | 932K | - |
| 2013 | 804K | - | -10.7M | -1.8M | - |
| 2012 | 0 | - | -10.2M | 8.9M | - |
Official annual report
Find more companies like VIPERGEN R & D III K/S
Build lead lists with filters on industry, geography, size and financials, and export straight to Excel.
Try the lead list generatorEvents in 2016
VIPERGEN R & D III K/S has published its annual report for 2015. Revenue came to DKK 0, and the net result was DKK -932,000.
About VIPERGEN R & D III K/S
VIPERGEN R & D III K/S was a Danish company of the type Kommanditselskab based in København V, founded in 2007. The company has been dissolved on 31 May 2019. The company was registered under the industry Forskning og eksperimentel udvikling indenfor bioteknologi. In 2018, the company reported a gross profit of DKK -10,000 and a net result of DKK -7,000 compared with DKK 211,000 the year before. Equity in the 2018 report amounted to DKK 152,000.